Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial)

Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in typ...

Full description

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 58; no. 4; pp. 1287 - 1295
Main Authors Bacchi, Elisabetta, Negri, Carlo, Targher, Giovanni, Faccioli, Niccolò, Lanza, Massimo, Zoppini, Giacomo, Zanolin, Elisabetta, Schena, Federico, Bonora, Enzo, Moghetti, Paolo
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health, Inc 01.10.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4‐month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual‐energy X‐ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in‐opposed‐phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] −32.8% [−58.20 to −7.52] versus −25.9% [−50.92 to −0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one‐quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. Conclusion: This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. (Hepatology 2013;58:1287–1295)
AbstractList Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P<0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. Conclusion: This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. (Hepatology 2013;58:1287-1295) [PUBLICATION ABSTRACT]
Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4‐month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual‐energy X‐ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in‐opposed‐phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] −32.8% [−58.20 to −7.52] versus −25.9% [−50.92 to −0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one‐quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. Conclusion: This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. (Hepatology 2013;58:1287–1295)
Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD.
Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups.UNLABELLEDAlthough lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups.This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD.CONCLUSIONThis is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD.
Author Zanolin, Elisabetta
Bonora, Enzo
Zoppini, Giacomo
Moghetti, Paolo
Targher, Giovanni
Negri, Carlo
Faccioli, Niccolò
Schena, Federico
Bacchi, Elisabetta
Lanza, Massimo
Author_xml – sequence: 1
  givenname: Elisabetta
  surname: Bacchi
  fullname: Bacchi, Elisabetta
  organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 2
  givenname: Carlo
  surname: Negri
  fullname: Negri, Carlo
  organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 3
  givenname: Giovanni
  surname: Targher
  fullname: Targher, Giovanni
  organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 4
  givenname: Niccolò
  surname: Faccioli
  fullname: Faccioli, Niccolò
  organization: Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 5
  givenname: Massimo
  surname: Lanza
  fullname: Lanza, Massimo
  organization: University of Verona
– sequence: 6
  givenname: Giacomo
  surname: Zoppini
  fullname: Zoppini, Giacomo
  organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 7
  givenname: Elisabetta
  surname: Zanolin
  fullname: Zanolin, Elisabetta
  organization: University of Verona
– sequence: 8
  givenname: Federico
  surname: Schena
  fullname: Schena, Federico
  organization: University of Verona
– sequence: 9
  givenname: Enzo
  surname: Bonora
  fullname: Bonora, Enzo
  organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 10
  givenname: Paolo
  surname: Moghetti
  fullname: Moghetti, Paolo
  organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23504926$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1uEzEUhS1URNPAghdAlti0i2n9M5mxl6UEilQJhGBt2Z47xNFkHGwPVXghXpMbkgqpAi9syfc799jnnpGTMY5AyEvOLjlj4moF20vRSC2fkBlfiLaScsFOyIyJllWaS31KznJeM8Z0LdQzciqwXmvRzMivN7GsaIIccrGjB1qSDWMYv1E7dtRCii74v5cJugkhNLQF73tbqI9jgbHQMNKy2wIVtAvWwb6cJ7cGXzK9D2iCj7aDj6s4HJRlR4fwAxLyGWwGel5WQD9fL98KmtA9bsJP6NA72OHiOXna2yHDi-M5J1_fLb_c3FZ3H99_uLm-q7xUSla6sYw3qq2dc75TTvXAlYXaddqCZGphhexU3bKaqZ5p2WB-esGtUx2WQcs5OT_03ab4fYJczCZkD8NgR4hTNryupdStxn1OXj9C13FK-Mc9JTXTHBdSr47U5DbQmW0KG5t25mEECFwdAJ9izgl640PBdDFWTH0wnJn9kA1mbv4MGRUXjxQPTf_FHrvfhwF2_wfN7fLTQfEbVuG26w
CODEN HPTLD9
CitedBy_id crossref_primary_10_1186_s13102_024_00972_9
crossref_primary_10_1136_bmjsem_2016_000143
crossref_primary_10_1177_20420188231160394
crossref_primary_10_1152_ajpendo_00019_2020
crossref_primary_10_1016_j_cmet_2023_12_008
crossref_primary_10_1038_srep43029
crossref_primary_10_1002_pdi_2311
crossref_primary_10_3389_fendo_2021_655756
crossref_primary_10_1186_s12889_018_5069_6
crossref_primary_10_1249_MSS_0000000000003199
crossref_primary_10_3389_fendo_2020_592373
crossref_primary_10_1530_JOE_18_0567
crossref_primary_10_1186_s12902_022_01212_2
crossref_primary_10_3390_ijms22073469
crossref_primary_10_1007_s11901_014_0229_3
crossref_primary_10_1080_17512433_2017_1300059
crossref_primary_10_1097_MEG_0000000000001135
crossref_primary_10_1155_2020_6412916
crossref_primary_10_1155_2022_3059629
crossref_primary_10_1016_j_dld_2015_08_004
crossref_primary_10_1080_17461391_2019_1571114
crossref_primary_10_2337_db17_0077
crossref_primary_10_1016_j_bpg_2014_07_008
crossref_primary_10_1016_j_jhep_2015_03_009
crossref_primary_10_5717_jenb_2014_18_3_249
crossref_primary_10_29252_aassjournal_855
crossref_primary_10_1007_s40279_023_01918_w
crossref_primary_10_1210_clinem_dgad326
crossref_primary_10_14309_ctg_0000000000000371
crossref_primary_10_4254_wjh_v7_i16_2041
crossref_primary_10_1016_j_artere_2017_07_001
crossref_primary_10_5812_hepatmon_116513
crossref_primary_10_3390_jfmk2040035
crossref_primary_10_1177_2047487318805158
crossref_primary_10_1038_nrendo_2017_173
crossref_primary_10_3390_jcm9041115
crossref_primary_10_1007_s12020_024_03783_7
crossref_primary_10_1002_ueg2_12443
crossref_primary_10_1016_j_pbj_0000000000000002
crossref_primary_10_1159_000360511
crossref_primary_10_1080_13813455_2016_1202985
crossref_primary_10_4103_1110_6611_174717
crossref_primary_10_1016_j_clinthera_2021_01_021
crossref_primary_10_3748_wjg_v25_i28_3669
crossref_primary_10_1111_obr_13727
crossref_primary_10_1016_j_lfs_2022_120522
crossref_primary_10_1016_j_bbrc_2022_03_008
crossref_primary_10_1016_j_conctc_2022_100984
crossref_primary_10_2337_dc16_1728
crossref_primary_10_1007_s11101_023_09912_w
crossref_primary_10_1016_j_cld_2023_01_002
crossref_primary_10_1007_s11428_016_0144_z
crossref_primary_10_1139_apnm_2018_0635
crossref_primary_10_1586_17474124_2015_1075392
crossref_primary_10_3389_fphar_2016_00283
crossref_primary_10_1097_HC9_0000000000000108
crossref_primary_10_1371_journal_pone_0263931
crossref_primary_10_3390_jcm10081659
crossref_primary_10_1007_s12325_020_01281_6
crossref_primary_10_1016_j_bjpt_2017_06_004
crossref_primary_10_1016_j_jhep_2015_11_004
crossref_primary_10_1152_ajpcell_00144_2024
crossref_primary_10_1016_j_tem_2016_11_006
crossref_primary_10_1186_s13395_023_00333_z
crossref_primary_10_3389_fendo_2022_1032164
crossref_primary_10_3390_nu15183950
crossref_primary_10_1111_eci_12958
crossref_primary_10_1152_ajpcell_00405_2024
crossref_primary_10_1002_oby_21890
crossref_primary_10_3904_kjim_2017_343
crossref_primary_10_1136_bjsports_2016_096197
crossref_primary_10_2147_DMSO_S358256
crossref_primary_10_1038_s41598_023_31686_6
crossref_primary_10_1016_j_cgh_2016_04_036
crossref_primary_10_1586_17474124_2014_903798
crossref_primary_10_1007_s00392_020_01709_7
crossref_primary_10_1007_s00125_016_4068_3
crossref_primary_10_1016_j_conctc_2020_100560
crossref_primary_10_1136_bmjgast_2020_000381
crossref_primary_10_4103_tcmj_tcmj_86_20
crossref_primary_10_3390_ijerph19042350
crossref_primary_10_3390_nu15081990
crossref_primary_10_1016_j_ando_2020_05_003
crossref_primary_10_1177_1756283X16638830
crossref_primary_10_2217_pme_14_44
crossref_primary_10_1097_MEG_0000000000002662
crossref_primary_10_3390_physiologia5010010
crossref_primary_10_1177_2047487319850718
crossref_primary_10_3390_nu11122971
crossref_primary_10_2196_11250
crossref_primary_10_1097_MEG_0000000000002887
crossref_primary_10_3389_fendo_2020_00567
crossref_primary_10_1007_s11901_017_0374_6
crossref_primary_10_3389_fendo_2022_1075986
crossref_primary_10_1007_s40279_022_01724_w
crossref_primary_10_1007_s10620_016_4126_1
crossref_primary_10_1016_j_gastrohep_2020_05_020
crossref_primary_10_1186_s12986_017_0173_7
crossref_primary_10_1152_japplphysiol_00950_2015
crossref_primary_10_1007_s00125_020_05170_z
crossref_primary_10_1002_14651858_CD013156_pub2
crossref_primary_10_1155_2013_805217
crossref_primary_10_1249_JES_0000000000000296
crossref_primary_10_1002_mnfr_202000375
crossref_primary_10_1016_j_lfs_2021_120124
crossref_primary_10_3390_jcm10030467
crossref_primary_10_1016_S2213_8587_24_00377_2
crossref_primary_10_1097_TP_0000000000002483
crossref_primary_10_3389_fmed_2024_1291501
crossref_primary_10_1016_j_clinthera_2021_07_013
crossref_primary_10_1016_j_physbeh_2020_113149
crossref_primary_10_1007_s11332_018_0459_9
crossref_primary_10_20463_jenb_2019_0004
crossref_primary_10_1111_1753_0407_13086
crossref_primary_10_3390_ijms25115571
crossref_primary_10_1016_j_metabol_2016_12_006
crossref_primary_10_14309_ctg_0000000000000316
crossref_primary_10_1016_j_livres_2017_12_008
crossref_primary_10_1186_s12986_024_00871_3
crossref_primary_10_1016_j_livres_2017_12_006
crossref_primary_10_3389_fendo_2023_1081096
crossref_primary_10_1186_s12986_015_0026_1
crossref_primary_10_1002_dmrr_3677
crossref_primary_10_1016_j_metabol_2015_09_017
crossref_primary_10_1002_hep_26475
crossref_primary_10_1016_j_numecd_2020_08_021
crossref_primary_10_1111_liv_14852
crossref_primary_10_1111_liv_70068
crossref_primary_10_1002_hep_26477
crossref_primary_10_3920_CEP200075
crossref_primary_10_1016_j_jhep_2016_06_022
crossref_primary_10_1016_j_bbrc_2024_150305
crossref_primary_10_2337_dc16_1787
crossref_primary_10_1007_s13679_014_0126_7
crossref_primary_10_1016_j_obmed_2020_100233
crossref_primary_10_2147_DMSO_S304357
crossref_primary_10_3748_wjg_v22_i27_6318
crossref_primary_10_5812_hmj_97644
crossref_primary_10_1152_ajpendo_00266_2017
crossref_primary_10_3390_biomedicines9121853
crossref_primary_10_1111_liv_13332
crossref_primary_10_1007_s11332_020_00690_y
crossref_primary_10_1038_srep31560
crossref_primary_10_61186_jspac_19946_1_1_54
crossref_primary_10_1016_S0140_6736_23_00773_0
crossref_primary_10_1080_13813455_2021_1886117
crossref_primary_10_3390_nu13010066
crossref_primary_10_1016_j_clnu_2015_07_003
crossref_primary_10_61186_JBUMS_30_3_257
crossref_primary_10_1002_jmri_25845
crossref_primary_10_7570_kjo_2015_24_4_190
crossref_primary_10_1097_MOG_0000000000000060
crossref_primary_10_1002_oby_21032
crossref_primary_10_1007_s10620_016_4083_8
crossref_primary_10_3350_cmh_2018_0086
crossref_primary_10_1016_j_jnutbio_2022_108997
crossref_primary_10_1055_s_0041_1732354
crossref_primary_10_1177_20503121221124762
crossref_primary_10_1111_hepr_12781
crossref_primary_10_3390_ijms22052350
crossref_primary_10_1016_j_metabol_2015_10_032
crossref_primary_10_1586_17474124_2015_965143
crossref_primary_10_3389_fendo_2018_00588
crossref_primary_10_1016_j_gtc_2019_09_003
crossref_primary_10_3390_jcdd9120419
crossref_primary_10_4093_dmj_2019_0034
crossref_primary_10_1111_liv_13311
crossref_primary_10_1007_s00421_014_3031_6
crossref_primary_10_1111_1751_2980_12751
crossref_primary_10_1016_j_molmet_2021_101270
crossref_primary_10_3390_jcm14020428
crossref_primary_10_4158_EP161365_GL
crossref_primary_10_1016_j_arteri_2016_06_002
crossref_primary_10_1111_cen_14990
crossref_primary_10_1136_bmjgast_2017_000139
crossref_primary_10_3390_jcm12175603
crossref_primary_10_1016_j_lfs_2021_119639
crossref_primary_10_23949_kjpe_2018_03_57_2_40
crossref_primary_10_1177_20420188221122426
crossref_primary_10_4093_dmj_2020_0010
crossref_primary_10_1016_j_diabres_2018_08_011
crossref_primary_10_1152_ajpendo_00129_2023
crossref_primary_10_5223_pghn_2021_24_1_54
crossref_primary_10_1002_pmic_202300078
crossref_primary_10_1136_bmjsem_2023_001878
crossref_primary_10_1016_j_clinsp_2023_100288
crossref_primary_10_5812_jjcdc_90213
crossref_primary_10_1111_eci_13596
crossref_primary_10_2337_diaspect_28_1_39
crossref_primary_10_1016_S1957_2557_19_30186_5
crossref_primary_10_1055_a_0840_3330
crossref_primary_10_3727_105221617X15124844266408
crossref_primary_10_1111_dme_12725
crossref_primary_10_3390_cells11050872
crossref_primary_10_1186_2193_1801_3_336
crossref_primary_10_2217_pgs_2016_0047
crossref_primary_10_1007_s12020_018_1603_7
crossref_primary_10_1111_jgh_13856
crossref_primary_10_3390_jcm10092040
crossref_primary_10_1111_dom_16019
crossref_primary_10_3389_fnins_2018_00498
crossref_primary_10_1080_00913847_2018_1411171
crossref_primary_10_3164_jcbn_17_115
crossref_primary_10_5812_ijem_109021
crossref_primary_10_1111_jgh_15595
crossref_primary_10_1111_jcmm_12733
crossref_primary_10_1155_2013_309191
crossref_primary_10_3389_fnut_2024_1426551
crossref_primary_10_1016_j_biopha_2017_09_093
crossref_primary_10_3389_fnut_2022_1065188
crossref_primary_10_5717_jenb_2015_15070703
crossref_primary_10_1038_s41430_021_00928_z
crossref_primary_10_3350_cmh_2021_0178
crossref_primary_10_1249_MSS_0000000000003388
crossref_primary_10_1016_j_lfs_2020_118868
crossref_primary_10_3904_kjm_2014_86_4_416
crossref_primary_10_1155_2021_5554597
crossref_primary_10_3389_fnut_2021_734859
crossref_primary_10_1002_jmri_25083
crossref_primary_10_1111_obr_13275
crossref_primary_10_1042_BCJ20210185
crossref_primary_10_1007_s00535_014_0959_6
crossref_primary_10_1016_j_jhep_2016_08_019
crossref_primary_10_1016_j_biopha_2021_111803
crossref_primary_10_1123_jpah_2024_0334
crossref_primary_10_1111_joim_13203
crossref_primary_10_1016_j_dsx_2019_07_007
crossref_primary_10_1016_j_tem_2019_07_013
crossref_primary_10_1007_s00125_016_3902_y
crossref_primary_10_1016_j_jhep_2016_08_023
crossref_primary_10_3390_nu13093135
crossref_primary_10_1186_s43161_023_00164_5
crossref_primary_10_1093_nutrit_nuy022
crossref_primary_10_1136_bmjdrc_2022_002950
crossref_primary_10_1152_ajpendo_00292_2015
crossref_primary_10_1002_hep_28132
crossref_primary_10_1016_j_lfs_2024_123225
crossref_primary_10_2147_DMSO_S262289
crossref_primary_10_2337_dbi18_0043
crossref_primary_10_1139_apnm_2021_0168
crossref_primary_10_1007_s00125_016_4037_x
crossref_primary_10_1007_s00125_018_4618_y
crossref_primary_10_1159_000443344
crossref_primary_10_1016_S2213_8587_18_30154_2
crossref_primary_10_1111_1440_1681_13687
crossref_primary_10_1093_advances_nmaa090
crossref_primary_10_1089_met_2022_0069
crossref_primary_10_1177_1756284820941745
crossref_primary_10_1016_j_jshs_2022_01_006
crossref_primary_10_1016_j_dld_2022_12_013
crossref_primary_10_3748_wjg_v20_i36_12956
crossref_primary_10_1177_0300060517707672
crossref_primary_10_1002_jbio_202400274
crossref_primary_10_1016_j_jhep_2015_02_022
crossref_primary_10_3389_fendo_2017_00033
crossref_primary_10_5009_gnl230236
Cites_doi 10.1152/ajpendo.0327.2001
10.1093/clinchem/18.6.499
10.1016/j.jhep.2009.04.012
10.1002/jmri.22580
10.1002/(SICI)1098-2353(1996)9:1<19::AID-CA4>3.0.CO;2-V
10.1016/j.jhep.2009.05.023
10.2337/dc11-1655
10.1136/gut.2006.112094
10.1016/j.jhep.2011.06.010
10.1016/S0730-725X(96)00224-X
10.1097/RLI.0b013e31824baff3
10.1210/jc.2004-1959
10.1038/oby.2003.3
10.1002/hep.22525
10.1097/MOL.0b013e32833ea912
10.1001/jama.2011.576
10.1148/radiology.153.1.6089264
10.1093/ije/dyl245
10.1056/NEJMra0912063
10.1001/jama.286.10.1218
10.1038/nrgastro.2012.200
10.1148/rg.291075123
10.1002/hep.23129
10.2337/dc12-0033
10.1152/ajpendo.00064.2004
10.1136/gut.2011.242073
10.2337/dc11-1583
ContentType Journal Article
Copyright Copyright © 2013 by the American Association for the Study of Liver Diseases
Copyright © 2013 by the American Association for the Study of Liver Diseases.
Copyright_xml – notice: Copyright © 2013 by the American Association for the Study of Liver Diseases
– notice: Copyright © 2013 by the American Association for the Study of Liver Diseases.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
H94
K9.
7X8
DOI 10.1002/hep.26393
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3350
EndPage 1295
ExternalDocumentID 3088568001
23504926
10_1002_hep_26393
HEP26393
Genre article
Randomized Controlled Trial
Journal Article
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
186
1B1
1CY
1L6
1OB
1OC
1ZS
1~5
24P
31~
33P
3O-
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AANHP
AAONW
AAQFI
AAQQT
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABMAC
ABOCM
ABPVW
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACLDA
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AECAP
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD8
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
M65
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RGB
RIG
RIWAO
RJQFR
ROL
RPZ
RWI
RX1
RYL
SEW
SSZ
SUPJJ
TEORI
UB1
V2E
V9Y
W2D
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
X7M
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ABJNI
ACZKN
AFNMH
AGQPQ
AHQVU
CITATION
MEWTI
WXSBR
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c3883-96a016874bbbcd8b8fe18ae4bd9ae3085a23d8470408f0936100951ab8de30e93
IEDL.DBID DR2
ISSN 0270-9139
1527-3350
IngestDate Fri Jul 11 07:10:30 EDT 2025
Fri Jul 25 22:57:46 EDT 2025
Thu Apr 03 07:00:55 EDT 2025
Thu Apr 24 23:03:49 EDT 2025
Tue Jul 01 03:33:35 EDT 2025
Wed Jan 22 17:03:14 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright © 2013 by the American Association for the Study of Liver Diseases.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3883-96a016874bbbcd8b8fe18ae4bd9ae3085a23d8470408f0936100951ab8de30e93
Notes Potential conflict of interest: Nothing to report.
Supported in part by grants to Paolo Moghetti from the University of Verona and from the Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy. The funding sources had no involvement in the design, execution or analysis of the study.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26393
PMID 23504926
PQID 1439091111
PQPubID 996352
PageCount 9
ParticipantIDs proquest_miscellaneous_1443397943
proquest_journals_1439091111
pubmed_primary_23504926
crossref_citationtrail_10_1002_hep_26393
crossref_primary_10_1002_hep_26393
wiley_primary_10_1002_hep_26393_HEP26393
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2013
2013-10-00
2013-Oct
20131001
PublicationDateYYYYMMDD 2013-10-01
PublicationDate_xml – month: 10
  year: 2013
  text: October 2013
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Hepatology (Baltimore, Md.)
PublicationTitleAlternate Hepatology
PublicationYear 2013
Publisher Wolters Kluwer Health, Inc
Publisher_xml – name: Wolters Kluwer Health, Inc
References 2001; 286
2010; 33
2010; 59
2005; 90
2011; 60
2010; 363
2011; 34
2012; 35
2012; 56
2007; 56
2007; 36
1957; 35
2009; 29
2003; 11
2010; 21
1984; 153
2009; 51
2011; 305
2005; 288
2009; 50
2002; 283
1997; 15
2008; 48
2012; 47
1972; 18
1996; 9
2012; 9
Rodriguez (R5-15-20241201) 2012; 9
Miyazaki (R28-15-20241201) 2002; 283
Kang (R18-15-20241201) 2012; 47
Friedwald (R12-15-20241201) 1972; 18
ZelberSagi (R27-15-20241201) 2008; 48
Golan (R30-15-20241201) 2012; 35
Umpierre (R3-15-20241201) 2011; 305
Targher (R15-15-20241201) 2012; 35
Schwenzer (R31-15-20241201) 2009; 51
Hallsworth (R24-15-20241201) 2011; 60
Fishbein (R14-15-20241201) 1997; 15
Lee (R13-15-20241201) 1984; 153
Bozzetto (R23-15-20241201) 2012; 35
Magkos (R26-15-20241201) 2010; 21
Reeder (R32-15-20241201) 2011; 34
Karvonen (R11-15-20241201) 1957; 35
Bacchi (R10-15-20241201) 2012; 35
Targher (R1-15-20241201) 2010; 363
Shen (R20-15-20241201) 2003; 11
Tamura (R9-15-20241201) 2005; 90
McPherson (R17-15-20241201) 2009; 51
Cassidy (R19-15-20241201) 2009; 29
Johnson (R22-15-20241201) 2009; 50
Thoma (R4-15-20241201) 2012; 56
Szczepaniak (R16-15-20241201) 2005; 288
Sniderman (R29-15-20241201) 2007; 36
Johnson (R21-15-20241201) 1996; 9
Bonekamp (R6-15-20241201) 2008; 48
Harrison (R25-15-20241201) 2007; 56
Boule (R2-15-20241201) 2001; 286
23696196 - Hepatology. 2014 Jan;59(1):351-2
24516886 - Hepatology. 2014 Jan;59(1):352
References_xml – volume: 35
  start-page: 676
  year: 2012
  end-page: 682
  article-title: Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study)
  publication-title: Diabetes Care
– volume: 9
  start-page: 726
  year: 2012
  end-page: 731
  article-title: Physical activity: an essential component of lifestyle modification in NAFLD
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 286
  start-page: 1218
  year: 2001
  end-page: 1227
  article-title: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials
  publication-title: JAMA
– volume: 288
  start-page: E462
  year: 2005
  end-page: E468
  article-title: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
  publication-title: Am J Physiol Endocrinol Metab
– volume: 33
  start-page: 2156
  year: 2010
  end-page: 2163
  article-title: Effect of a 12‐month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes
  publication-title: Diabetes Care
– volume: 59
  start-page: 627
  year: 2010
  end-page: 633
  article-title: Metabolic changes following a 1‐year diet and exercise intervention in patients with type 2 diabetes
  publication-title: Diabetes
– volume: 15
  start-page: 287
  year: 1997
  end-page: 293
  article-title: Introduction of fast MR imaging in the assessment of hepatic steatosis
  publication-title: Magn Reson Imaging
– volume: 48
  start-page: 806A
  year: 2008
  article-title: The effect of an exercise training intervention on hepatic steatosis [Abstract]
  publication-title: Hepatology
– volume: 47
  start-page: 368
  year: 2012
  end-page: 375
  article-title: Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical‐shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard
  publication-title: Invest Radiol
– volume: 33
  start-page: e147
  year: 2010
  end-page: e167
  article-title: Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement
  publication-title: Diabetes Care
– volume: 29
  start-page: 231
  year: 2009
  end-page: 260
  article-title: Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis
  publication-title: Radiographics
– volume: 35
  start-page: 1429
  year: 2012
  end-page: 1435
  article-title: Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients
  publication-title: Diabetes Care
– volume: 56
  start-page: 255
  year: 2012
  end-page: 266
  article-title: Lifestyle interventions for the treatment of non‐alcoholic fatty liver disease in adults: a systematic review
  publication-title: J Hepatol
– volume: 283
  start-page: E1135
  year: 2002
  end-page: 1143
  article-title: Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus
  publication-title: Am J Physiol Endocrinol Metab
– volume: 9
  start-page: 19
  year: 1996
  end-page: 24
  article-title: The abdominal subcutaneous tissue: computed tomographic, magnetic resonance, and anatomical observations
  publication-title: Clin Anat
– volume: 11
  start-page: 5
  year: 2003
  end-page: 15
  article-title: Adipose tissue quantification by imaging methods: a proposed classification
  publication-title: Obes Res
– volume: 56
  start-page: 1760
  year: 2007
  end-page: 1769
  article-title: Benefits of lifestyle modification in NAFLD
  publication-title: Gut
– volume: 363
  start-page: 1341
  year: 2010
  end-page: 1350
  article-title: Risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
  publication-title: N Engl J Med
– volume: 48
  start-page: 1791
  year: 2008
  end-page: 1798
  article-title: Role of leisure‐time physical activity in non‐alcoholic fatty liver disease: a population‐based study
  publication-title: Hepatology
– volume: 50
  start-page: 1105
  year: 2009
  end-page: 1112
  article-title: Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss
  publication-title: Hepatology
– volume: 51
  start-page: 433
  year: 2009
  end-page: 445
  article-title: Non‐invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
  publication-title: J Hepatol
– volume: 305
  start-page: 1790
  year: 2011
  end-page: 1799
  article-title: Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta‐analysis
  publication-title: JAMA
– volume: 153
  start-page: 195
  year: 1984
  end-page: 201
  article-title: Fatty infiltration of the liver: demonstration by proton spectroscopic imaging
  publication-title: Preliminary observations. Radiology
– volume: 34
  start-page: 729
  year: 2011
  end-page: 749
  article-title: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
  publication-title: J Magn Reson Imaging
– volume: 60
  start-page: 1278
  year: 2011
  end-page: 1283
  article-title: Resistance exercise reduces liver fat and its mediators in non‐alcoholic fatty liver disease independent of weight loss
  publication-title: Gut
– volume: 21
  start-page: 507
  year: 2010
  end-page: 517
  article-title: Exercise and fat accumulation in the human liver
  publication-title: Curr Opin Lipidol
– volume: 90
  start-page: 3191
  year: 2005
  end-page: 3196
  article-title: Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type2 diabetic patients
  publication-title: J Clin Endocrinol Metab
– volume: 35
  start-page: 748
  year: 2012
  end-page: 753
  article-title: Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals
  publication-title: J Endocrinol Invest
– volume: 36
  start-page: 220
  year: 2007
  end-page: 225
  article-title: Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis
  publication-title: Int J Epidemiol
– volume: 51
  start-page: 389
  year: 2009
  end-page: 397
  article-title: Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered
  publication-title: J Hepatol
– volume: 35
  start-page: 640
  year: 2012
  end-page: 647
  article-title: Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes
  publication-title: Diabetes Care
– volume: 35
  start-page: 307
  year: 1957
  end-page: 315
  article-title: The effects of training on heart rate; a longitudinal study
  publication-title: Ann Med Exp Biol Fenn
– volume: 18
  start-page: 499
  year: 1972
  end-page: 502
  article-title: Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin Chem
– volume: 283
  start-page: E1135
  year: 2002
  ident: R28-15-20241201
  article-title: Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.0327.2001
– volume: 18
  start-page: 499
  year: 1972
  ident: R12-15-20241201
  article-title: Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
  publication-title: Clin Chem
  doi: 10.1093/clinchem/18.6.499
– volume: 51
  start-page: 389
  year: 2009
  ident: R17-15-20241201
  article-title: Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2009.04.012
– volume: 34
  start-page: 729
  year: 2011
  ident: R32-15-20241201
  article-title: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.22580
– volume: 9
  start-page: 19
  year: 1996
  ident: R21-15-20241201
  article-title: The abdominal subcutaneous tissue: computed tomographic, magnetic resonance, and anatomical observations.
  publication-title: Clin Anat
  doi: 10.1002/(SICI)1098-2353(1996)9:1<19::AID-CA4>3.0.CO;2-V
– volume: 51
  start-page: 433
  year: 2009
  ident: R31-15-20241201
  article-title: Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2009.05.023
– volume: 35
  start-page: 676
  year: 2012
  ident: R10-15-20241201
  article-title: Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study).
  publication-title: Diabetes Care
  doi: 10.2337/dc11-1655
– volume: 56
  start-page: 1760
  year: 2007
  ident: R25-15-20241201
  article-title: Benefits of lifestyle modification in NAFLD.
  publication-title: Gut
  doi: 10.1136/gut.2006.112094
– volume: 35
  start-page: 748
  year: 2012
  ident: R15-15-20241201
  article-title: Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals.
  publication-title: J Endocrinol Invest
– volume: 48
  start-page: 806A
  year: 2008
  ident: R6-15-20241201
  article-title: The effect of an exercise training intervention on hepatic steatosis Abstract.
  publication-title: Hepatology
– volume: 56
  start-page: 255
  year: 2012
  ident: R4-15-20241201
  article-title: Lifestyle interventions for the treatment of nonalcoholic fatty liver disease in adults: a systematic review.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.06.010
– volume: 15
  start-page: 287
  year: 1997
  ident: R14-15-20241201
  article-title: Introduction of fast MR imaging in the assessment of hepatic steatosis.
  publication-title: Magn Reson Imaging
  doi: 10.1016/S0730-725X(96)00224-X
– volume: 47
  start-page: 368
  year: 2012
  ident: R18-15-20241201
  article-title: Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemicalshift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
  publication-title: Invest Radiol
  doi: 10.1097/RLI.0b013e31824baff3
– volume: 90
  start-page: 3191
  year: 2005
  ident: R9-15-20241201
  article-title: Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type2 diabetic patients.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1959
– volume: 11
  start-page: 5
  year: 2003
  ident: R20-15-20241201
  article-title: Adipose tissue quantification by imaging methods: a proposed classification.
  publication-title: Obes Res
  doi: 10.1038/oby.2003.3
– volume: 48
  start-page: 1791
  year: 2008
  ident: R27-15-20241201
  article-title: Role of leisuretime physical activity in nonalcoholic fatty liver disease: a populationbased study.
  publication-title: Hepatology
  doi: 10.1002/hep.22525
– volume: 21
  start-page: 507
  year: 2010
  ident: R26-15-20241201
  article-title: Exercise and fat accumulation in the human liver.
  publication-title: Curr Opin Lipidol
  doi: 10.1097/MOL.0b013e32833ea912
– volume: 305
  start-page: 1790
  year: 2011
  ident: R3-15-20241201
  article-title: Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and metaanalysis.
  publication-title: JAMA
  doi: 10.1001/jama.2011.576
– volume: 153
  start-page: 195
  year: 1984
  ident: R13-15-20241201
  article-title: Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Preliminary observations.
  publication-title: Radiology
  doi: 10.1148/radiology.153.1.6089264
– volume: 36
  start-page: 220
  year: 2007
  ident: R29-15-20241201
  article-title: Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis.
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyl245
– volume: 363
  start-page: 1341
  year: 2010
  ident: R1-15-20241201
  article-title: Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra0912063
– volume: 286
  start-page: 1218
  year: 2001
  ident: R2-15-20241201
  article-title: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a metaanalysis of controlled clinical trials.
  publication-title: JAMA
  doi: 10.1001/jama.286.10.1218
– volume: 9
  start-page: 726
  year: 2012
  ident: R5-15-20241201
  article-title: Physical activity: an essential component of lifestyle modification in NAFLD.
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2012.200
– volume: 29
  start-page: 231
  year: 2009
  ident: R19-15-20241201
  article-title: Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.
  publication-title: Radiographics
  doi: 10.1148/rg.291075123
– volume: 50
  start-page: 1105
  year: 2009
  ident: R22-15-20241201
  article-title: Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.
  publication-title: Hepatology
  doi: 10.1002/hep.23129
– volume: 35
  start-page: 307
  year: 1957
  ident: R11-15-20241201
  article-title: The effects of training on heart rate; a longitudinal study.
  publication-title: Ann Med Exp Biol Fenn
– volume: 35
  start-page: 1429
  year: 2012
  ident: R23-15-20241201
  article-title: Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients.
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0033
– volume: 288
  start-page: E462
  year: 2005
  ident: R16-15-20241201
  article-title: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00064.2004
– volume: 60
  start-page: 1278
  year: 2011
  ident: R24-15-20241201
  article-title: Resistance exercise reduces liver fat and its mediators in nonalcoholic fatty liver disease independent of weight loss.
  publication-title: Gut
  doi: 10.1136/gut.2011.242073
– volume: 35
  start-page: 640
  year: 2012
  ident: R30-15-20241201
  article-title: Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes.
  publication-title: Diabetes Care
  doi: 10.2337/dc11-1583
– reference: 24516886 - Hepatology. 2014 Jan;59(1):352
– reference: 23696196 - Hepatology. 2014 Jan;59(1):351-2
SSID ssj0009428
Score 2.554632
Snippet Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with...
Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1287
SubjectTerms Body Composition - physiology
Comorbidity
Confidence intervals
Diabetes
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - physiopathology
Diet
Exercise
Fatty Liver - epidemiology
Fatty Liver - metabolism
Fatty Liver - physiopathology
Female
Hepatology
Humans
Insulin
Insulin Resistance - physiology
Intervention
Lipid Metabolism - physiology
Liver - metabolism
Liver diseases
Magnetic Resonance Imaging
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Resistance Training
Subcutaneous Fat - pathology
Treatment Outcome
Title Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial)
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.26393
https://www.ncbi.nlm.nih.gov/pubmed/23504926
https://www.proquest.com/docview/1439091111
https://www.proquest.com/docview/1443397943
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELYQDxMvYxtsdGPTDfHQPaSkdkhs7YltRRUSCFVU6sOkyI4dUVECIunD-If2b-7O-VHBhoT2FtVO7Dp3vu98l-8Y21dJiKjeqCCxmQwiF2vcB60NEhcbtNeJ4f4LudOzeDyNTmaHszX2tf0WpuaH6A7cSDP8fk0Krk15sCINvXS3A472lZg-KVeLANFkRR2lIl9XFb2ukKLLqmUVCvlBd-dDW_QXwHyIV73BOd5kP9up1nkmV4NlZQbZ_SMWx__8L6_YywaIwlEtOa_ZmivesBenTah9i_3-hu8Q0BkngImSAW0xCdCFBe2Ivylb_XhHFLAOcAiigIVcV0BZ8GjSYF4AHfQCh_qgF5vLpaHznxLoGBgK8gZ8pd76zuoXLChdBJroEfQRpcLkaPSDA5pWe3M9v3cWfMGRL9tsejy6-D4OmqoOQSakFIGKNcJMmUTGmMxKI3M3lNpFxirtBCJAzYVFm4m7i8xDJRDfEQzURlpsdkq8Zes4L7fDQCinBZeZQicOjexQ8ziJbK6N0irnzvZYv32_adZQntO6LNKarJmnuCqpX_ge2-u63tY8H__qtNsKSdqoeom-k1AhmYxhj33umlFJKfKiC3ezpD6RoABqhI94VwtXNwoXhyGxNuJkvYg8PXw6Hp37i_fP7_qBbXAq4OHTD3fZenW3dB8RRlXmk9eXPya9GUs
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXKO-FFgbEoRyyzdppYku9tLDVAt0KVa3USxXZsSMqSlp1swf6h_ibzDiPVXlIiFu0dmKvM-P5Zsb5BuCNzmJC9VZHmStUlPjU0D7oXJT51JK9zqwIX8hN99PJUfLxePN4Cba6b2Eafog-4MaaEfZrVnAOSG8sWEO_-IuhIAMrb8BNrugdHKqDBXmUTkJlVfK7Ys4v645XKBYb_a3XrdFvEPM6Yg0mZ_cenHSTbU6afB3Oazssrn7hcfzff7MCd1ssituN8NyHJV89gFvTNtv-EH7s0GtE8scZY5JwYFdPAk3l0HimcCoWP14yC6xHGoJZYLE0NfJBeLJqeFohx3pRYBPrpebZ3HIIaIYcCcaKHYJQrLe5s_6OZ3xiBNsEEq4TUMWD7fF7gWRd3fm30yvvMNQcefsIjnbHh-8mUVvYISqkUjLSqSGkqbLEWls4ZVXpR8r4xDptvCQQaIR0ZDZpg1FlrCVBPEaCxipHzV7Lx7BM8_JPAaX2RgpVaPLjyM6OjEizxJXGaqNL4d0A1rsXnBct6zmvy1ne8DWLnFYlDws_gNd914uG6uNPnVY7KclbbZ-R-yR1zFZjNIBXfTPpKSdfTOXP59wnkZxDTegRTxrp6kcRcjNm4kaabJCRvw-fT8afw8Wzf-_6Em5PDqd7-d6H_U_P4Y7geh7hNOIqLNeXc79GqKq2L4Ly_ASiHR1m
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceFMWCgyIQzlkm7XTxBanwu5qebSqKir1gBTZsSMqSrrqZg_0D_E3mXEeq_KQELdo7cReZ8bzzYzzDcBLncWE6q2OMleoKPGpoX3QuSjzqSV7nVkRvpDbP0hnx8n7k92TNXjdfQvT8EP0ATfWjLBfs4LPXbmzIg394udDQfZVXoPrSRorFunx0Yo7SiehsCq5XTGnl3VHKxSLnf7Wq8boN4R5FbAGizO9BZ-7uTYHTb4Ol7UdFpe_0Dj-55-5DTdbJIp7jejcgTVf3YWN_TbXfg9-vKGXiOSNM8Ik0cCumgSayqHxTOBUrH68YA5YjzQEc8BiaWrkY_Bk0_C0Qo70osAm0kvNi6XlANACOQ6MFbsDoVRvc2f9Hc_4vAi26SPcJpiKR3uTsUCyre782-mldxgqjry6D8fTyae3s6gt6xAVUikZ6dQQzlRZYq0tnLKq9CNlfGKdNl4SBDRCOjKatL2oMtaSAB7jQGOVo2av5QNYp3n5h4BSeyOFKjR5cWRlR0akWeJKY7XRpfBuANvd-82LlvOc1-Usb9iaRU6rkoeFH8CLvuu8Ifr4U6etTkjyVtcX5DxJHbPNGA3ged9MWsqpF1P58yX3SSRnUBN6xGYjXP0oQu7GTNtIkw0i8vfh89nkMFw8-veuz2DjcDzNP747-PAYbggu5hGOIm7Ben2x9E8IUtX2aVCdn1YuHB4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Both+resistance+training+and+aerobic+training+reduce+hepatic+fat+content+in+type+2+diabetic+subjects+with+nonalcoholic+fatty+liver+disease+%28the+RAED2+randomized+trial%29&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Bacchi%2C+Elisabetta&rft.au=Negri%2C+Carlo&rft.au=Targher%2C+Giovanni&rft.au=Faccioli%2C+Niccol%C3%B2&rft.date=2013-10-01&rft.issn=0270-9139&rft.eissn=1527-3350&rft.volume=58&rft.issue=4&rft.spage=1287&rft.epage=1295&rft_id=info:doi/10.1002%2Fhep.26393&rft.externalDBID=10.1002%252Fhep.26393&rft.externalDocID=HEP26393
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon